SENNI MICHELE

Ruolo:
Professore straordinario a tempo determinato
Settore scientifico disciplinare:
Malattie dell'apparato cardiovascolare (MEDS-07/B)
Gruppo scientifico disciplinare:
MALATTIE DELL'APPARATO CARDIOVASCOLARE E MALATTIE DELL'APPARATO RESPIRATORIO (06/MEDS-07)
E-mail:
[email protected]
Telefono:
0352673565

Pubblicazioni

  • Saldarriaga, C., Zannad, F., Mcmullan, C., Xing, A., Gates, D., Anstrom, K., et al. (2025). Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial. EUROPEAN JOURNAL OF HEART FAILURE, 27(8), 1426-1435 [10.1002/ejhf.3598]. Dettaglio

  • Kondo, T., Jhund, P., Henderson, A., Claggett, B., Desai, A., Brinker, M., et al. (2025). The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF. EUROPEAN JOURNAL OF HEART FAILURE, 27(8), 1459-1471 [10.1002/ejhf.3669]. Dettaglio

  • Bhatt, A., Vaduganathan, M., Claggett, B., Jhund, P., Henderson, A., Lam, C., et al. (2025). Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial. JOURNAL OF CARDIAC FAILURE [10.1016/j.cardfail.2025.05.006]. Dettaglio

  • Cunningham, J., Claggett, B., Vaduganathan, M., Desai, A., Jhund, P., Lam, C., et al. (2025). Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial. EUROPEAN JOURNAL OF HEART FAILURE, 27(8), 1487-1491 [10.1002/ejhf.3694]. Dettaglio

  • Butt, J., Jhund, P., Henderson, A., Claggett, B., Desai, A., Lam, C., et al. (2025). Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial. EUROPEAN JOURNAL OF HEART FAILURE, 27(7), 1326-1341 [10.1002/ejhf.3649]. Dettaglio

Lista completa